← Back to Search

Corticosteroid

Group 1 for Uveitis (ACTHAR Trial)

Phase 2
Waitlist Available
Led By Quan D Nguyen, MD MSc
Research Sponsored by Quan Dong Nguyen
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 12
Awards & highlights

ACTHAR Trial Summary

The study aims to evaluate the potential role of ACTH gel in the management of non-infectious uveitis.

ACTHAR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of ocular adverse events (AEs)
Incidence of systemic adverse events (AEs)
Secondary outcome measures
Change from Baseline in macular thickness
Mean change from BL in Best Corrected Visual Acuity (BCVA)
Mean change from BL in aqueous flare
+13 more

ACTHAR Trial Design

2Treatment groups
Experimental Treatment
Group I: Group 2Experimental Treatment1 Intervention
Mandatory thrice a week (Mondays, Wednesdays, and Fridays) treatment with SC ACTH gel 80 U/day starting at BL until month 6. Starting at month 6, the treatment will be administered on as needed basis, based on the retreatment criteria.
Group II: Group 1Experimental Treatment1 Intervention
Mandatory twice a week (Mondays and Thursdays) treatment with SC ACTH gel 80 U/day starting at BL until month 6. Starting at month 6, the treatment will be administered on as needed basis, based on the retreatment criteria.

Find a Location

Who is running the clinical trial?

Quan Dong NguyenLead Sponsor
2 Previous Clinical Trials
36 Total Patients Enrolled
2 Trials studying Uveitis
36 Patients Enrolled for Uveitis
MallinckrodtIndustry Sponsor
201 Previous Clinical Trials
16,192 Total Patients Enrolled
4 Trials studying Uveitis
22 Patients Enrolled for Uveitis
Quan D Nguyen, MD MScPrincipal InvestigatorOcular Imaging Research and Reading Center
1 Previous Clinical Trials
1 Trials studying Uveitis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)
Quan Dong Nguyen 2017. "ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02931175.
All > Acth > Uveitis
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top